Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis.
COVID-19
Idiopathic pulmonary fibrosis
Post-COVID-19 lung fibrosis
microRNA
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
15 Apr 2023
15 Apr 2023
Historique:
received:
21
11
2022
accepted:
03
04
2023
medline:
18
4
2023
entrez:
15
4
2023
pubmed:
16
4
2023
Statut:
epublish
Résumé
Pulmonary fibrosis is an emerging complication of SARS-CoV-2 infection. In this study, we speculate that patients with COVID-19 and idiopathic pulmonary fibrosis (IPF) may share aberrant expressed microRNAs (miRNAs) associated to the progression of lung fibrosis. To identify miRNAs presenting similar alteration in COVID-19 and IPF, and describe their impact on fibrogenesis. A systematic review of the literature published between 2010 and January 2022 (PROSPERO, CRD42022341016) was conducted using the key words (COVID-19 OR SARS-CoV-2) AND (microRNA OR miRNA) or (idiopathic pulmonary fibrosis OR IPF) AND (microRNA OR miRNA) in Title/Abstract. Of the 1988 references considered, 70 original articles were appropriate for data extraction: 27 studies focused on miRNAs in COVID-19, and 43 on miRNAs in IPF. 34 miRNAs were overlapping in COVID-19 and IPF, 7 miRNAs presenting an upregulation (miR-19a-3p, miR-200c-3p, miR-21-5p, miR-145-5p, miR-199a-5p, miR-23b and miR-424) and 9 miRNAs a downregulation (miR-17-5p, miR-20a-5p, miR-92a-3p, miR-141-3p, miR-16-5p, miR-142-5p, miR-486-5p, miR-708-3p and miR-150-5p). Several studies reported elevated levels of profibrotic miRNAs in COVID-19 context. In addition, the balance of antifibrotic miRNAs responsible of the modulation of fibrotic processes is impaired in COVID-19. This evidence suggests that the deregulation of fibrotic-related miRNAs participates in the development of fibrotic lesions in the lung of post-COVID-19 patients.
Sections du résumé
BACKGROUND
BACKGROUND
Pulmonary fibrosis is an emerging complication of SARS-CoV-2 infection. In this study, we speculate that patients with COVID-19 and idiopathic pulmonary fibrosis (IPF) may share aberrant expressed microRNAs (miRNAs) associated to the progression of lung fibrosis.
OBJECTIVE
OBJECTIVE
To identify miRNAs presenting similar alteration in COVID-19 and IPF, and describe their impact on fibrogenesis.
METHODS
METHODS
A systematic review of the literature published between 2010 and January 2022 (PROSPERO, CRD42022341016) was conducted using the key words (COVID-19 OR SARS-CoV-2) AND (microRNA OR miRNA) or (idiopathic pulmonary fibrosis OR IPF) AND (microRNA OR miRNA) in Title/Abstract.
RESULTS
RESULTS
Of the 1988 references considered, 70 original articles were appropriate for data extraction: 27 studies focused on miRNAs in COVID-19, and 43 on miRNAs in IPF. 34 miRNAs were overlapping in COVID-19 and IPF, 7 miRNAs presenting an upregulation (miR-19a-3p, miR-200c-3p, miR-21-5p, miR-145-5p, miR-199a-5p, miR-23b and miR-424) and 9 miRNAs a downregulation (miR-17-5p, miR-20a-5p, miR-92a-3p, miR-141-3p, miR-16-5p, miR-142-5p, miR-486-5p, miR-708-3p and miR-150-5p).
CONCLUSION
CONCLUSIONS
Several studies reported elevated levels of profibrotic miRNAs in COVID-19 context. In addition, the balance of antifibrotic miRNAs responsible of the modulation of fibrotic processes is impaired in COVID-19. This evidence suggests that the deregulation of fibrotic-related miRNAs participates in the development of fibrotic lesions in the lung of post-COVID-19 patients.
Identifiants
pubmed: 37061683
doi: 10.1186/s12931-023-02413-6
pii: 10.1186/s12931-023-02413-6
pmc: PMC10105547
doi:
Substances chimiques
MicroRNAs
0
MIRN145 microRNA, human
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
112Informations de copyright
© 2023. The Author(s).
Références
BMC Pulm Med. 2021 Jun 4;21(1):188
pubmed: 34088304
Cell Death Dis. 2020 Aug 7;11(8):639
pubmed: 32801294
Int J Infect Dis. 2021 Aug;109:209-216
pubmed: 34273510
Front Genet. 2014 Dec 10;5:422
pubmed: 25540650
J Mol Cell Cardiol. 2020 Nov;148:46-49
pubmed: 32891636
Mol Med Rep. 2018 Jan;17(1):1041-1048
pubmed: 29115493
Viruses. 2021 Aug 11;13(8):
pubmed: 34452458
Microb Pathog. 2021 Sep;158:105051
pubmed: 34153417
Cardiovasc Diabetol. 2022 Feb 24;21(1):31
pubmed: 35209901
FASEB J. 2013 Jun;27(6):2382-91
pubmed: 23457217
Arch Biochem Biophys. 2015 Jan 15;566:49-57
pubmed: 25524739
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Respir Res. 2013 Sep 24;14:95
pubmed: 24063588
J Exp Med. 2010 Aug 2;207(8):1589-97
pubmed: 20643828
Cells. 2021 Jul 15;10(7):
pubmed: 34359957
Respir Res. 2016 Sep 05;17(1):110
pubmed: 27596748
Int J Mol Sci. 2020 Jul 07;21(13):
pubmed: 32645951
Oncol Rep. 2018 Jan;39(1):247-254
pubmed: 29138833
Biochem Biophys Res Commun. 2021 Jul 5;561:113-119
pubmed: 34022711
Int J Mol Med. 2014 Jun;33(6):1554-62
pubmed: 24676360
Int J Biochem Cell Biol. 2014 Aug;53:432-41
pubmed: 24953558
Am J Respir Cell Mol Biol. 2020 Nov;63(5):623-636
pubmed: 32730709
Lancet Respir Med. 2020 Aug;8(8):807-815
pubmed: 32422178
Lancet Respir Med. 2021 Jan;9(1):85-95
pubmed: 32822614
Biomedicines. 2020 Oct 30;8(11):
pubmed: 33143053
J Biol Chem. 2019 Oct 11;294(41):15052-15067
pubmed: 31431501
Eur Respir Rev. 2017 May 17;26(144):
pubmed: 28515040
PLoS One. 2016 Jun 30;11(6):e0158367
pubmed: 27362652
Nat Commun. 2015 Oct 05;6:8523
pubmed: 26436920
Nature. 2005 Jun 9;435(7043):828-33
pubmed: 15944707
Transl Res. 2021 Feb;228:1-12
pubmed: 32711186
Front Genet. 2020 Jul 10;11:765
pubmed: 32765592
Mediators Inflamm. 2021 Apr 1;2021:6635925
pubmed: 33833618
Acta Clin Belg. 2018 Apr;73(2):139-143
pubmed: 29125071
Int J Med Sci. 2022 Jul 18;19(8):1340-1356
pubmed: 35928726
Oncotarget. 2016 Nov 15;7(46):74569-74581
pubmed: 27769060
Eur J Heart Fail. 2021 Mar;23(3):468-475
pubmed: 33421274
IDCases. 2020 Dec 31;23:e01041
pubmed: 33425682
Gene. 2015 May 10;562(1):138-44
pubmed: 25725128
Am J Respir Cell Mol Biol. 2017 Dec;57(6):721-732
pubmed: 28799781
Am J Pathol. 2012 Feb;180(2):484-93
pubmed: 22189082
Rheumatology (Oxford). 2012 Sep;51(9):1550-6
pubmed: 22661558
Life Sci. 2017 Oct 15;187:22-30
pubmed: 28823564
Am J Respir Cell Mol Biol. 2016 Jun;54(6):843-52
pubmed: 26600197
N Engl J Med. 2018 May 10;378(19):1811-1823
pubmed: 29742380
Cancer Res. 2004 May 1;64(9):3087-95
pubmed: 15126345
Blood. 2015 May 14;125(20):3202-12
pubmed: 25838349
SN Compr Clin Med. 2020;2(8):1069-1076
pubmed: 32838147
J Cell Biochem. 2018 Sep;119(9):7834-7843
pubmed: 29943845
Int J Mol Med. 2016 Nov;38(5):1377-1386
pubmed: 28025989
Sci Rep. 2014 Apr 03;4:4578
pubmed: 24694752
Respir Med. 2021 Nov;188:106602
pubmed: 34536697
Thorax. 2020 Oct;75(10):870-881
pubmed: 32759383
Exp Ther Med. 2015 Aug;10(2):683-688
pubmed: 26622375
Biochem Pharmacol. 2020 Oct;180:114172
pubmed: 32712053
Genes Dis. 2020 Dec;7(4):542-550
pubmed: 32363223
RNA Biol. 2022 Jan;19(1):1-11
pubmed: 34904915
Lancet. 2011 Dec 3;378(9807):1949-61
pubmed: 21719092
Expert Rev Respir Med. 2020 Nov;14(11):1149-1163
pubmed: 32734777
Infect Genet Evol. 2021 Jul;91:104832
pubmed: 33812037
J Extracell Vesicles. 2021 Jun;10(8):e12110
pubmed: 34122779
J Hepatol. 2009 Apr;50(4):766-78
pubmed: 19232449
Ann Med Surg (Lond). 2022 May;77:103590
pubmed: 35411216
Eur J Med Res. 2021 Jul 13;26(1):75
pubmed: 34256840
Lancet. 2011 May 21;377(9779):1760-9
pubmed: 21571362
Noncoding RNA Res. 2020 Sep;5(3):135-143
pubmed: 32839745
PLoS Pathog. 2021 Jul 28;17(7):e1009759
pubmed: 34320031
Int J Mol Sci. 2021 Sep 10;22(18):
pubmed: 34575957
Thorax. 2019 Mar;74(3):309-312
pubmed: 30244194
Thorax. 2021 Sep;76(9):895-906
pubmed: 33859055
Thorax. 2021 Dec;76(12):1242-1245
pubmed: 33927016
J Family Med Prim Care. 2021 May;10(5):2028-2031
pubmed: 34195143
Front Mol Biosci. 2021 Jul 15;8:640042
pubmed: 34336922
Immunol Rev. 2021 Jul;302(1):228-240
pubmed: 34028807
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Sci Rep. 2015 Sep 15;5:14131
pubmed: 26370615
Cell Death Differ. 2019 Sep;26(9):1832-1844
pubmed: 30644438
Cell Death Dis. 2019 Feb 12;10(2):129
pubmed: 30755599
EBioMedicine. 2021 Mar;65:103277
pubmed: 33714028
Mol Biol Res Commun. 2021 Sep;10(3):141-147
pubmed: 34476267
Int J Mol Med. 2015 Feb;35(2):311-8
pubmed: 25421593
Genes (Basel). 2018 Nov 29;9(12):
pubmed: 30501089
Int Immunopharmacol. 2021 Aug;97:107641
pubmed: 33895478
Nat Cell Biol. 2008 May;10(5):593-601
pubmed: 18376396
J Exp Med. 2011 Jul 4;208(7):1339-50
pubmed: 21727191
Am J Respir Crit Care Med. 2013 Feb 15;187(4):397-405
pubmed: 23306545
PLoS Genet. 2013;9(2):e1003291
pubmed: 23459460
Infect Genet Evol. 2021 Oct;94:105020
pubmed: 34343725
J Asthma. 2013 Nov;50(9):960-4
pubmed: 23822889
Genes (Basel). 2020 Aug 26;11(9):
pubmed: 32858958
Trends Endocrinol Metab. 2017 Mar;28(3):237-246
pubmed: 27989505
Exp Cell Res. 2021 Jan 15;398(2):112416
pubmed: 33307020
J Biol Chem. 2008 May 30;283(22):14910-4
pubmed: 18411277
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L444-L455
pubmed: 32755307
Am J Physiol Lung Cell Mol Physiol. 2014 Oct 15;307(8):L632-42
pubmed: 25172912
J Extracell Vesicles. 2022 Jun;11(6):e12228
pubmed: 35656866
Mol Med. 2017 Mar;23:24-33
pubmed: 28182191
Aging (Albany NY). 2020 Dec 19;13(2):2640-2654
pubmed: 33411678
Transl Res. 2021 Oct;236:147-159
pubmed: 34048985
Nature. 2008 Sep 4;455(7209):64-71
pubmed: 18668037
J Biol Chem. 2017 Oct 6;292(40):16420-16439
pubmed: 28726637
Clin Transl Med. 2020 Oct;10(6):e200
pubmed: 33135345
Exp Mol Med. 2018 Mar 30;50(3):e465
pubmed: 29869625
Vaccines (Basel). 2021 Sep 23;9(10):
pubmed: 34696164
Int J Surg. 2010;8(5):336-41
pubmed: 20171303